291 related articles for article (PubMed ID: 23808618)
21. Effect of anxiolytic drug silexan on sleep - a narrative review.
Seifritz E; Kasper S; Möller HJ; Volz HP; Müller WE; Eckert A; Hatzinger M
World J Biol Psychiatry; 2022 Sep; 23(7):493-500. PubMed ID: 36259937
[TBL] [Abstract][Full Text] [Related]
22. Silexan does not cause withdrawal symptoms even when abruptly discontinued.
Gastpar M; Müller WE; Volz HP; Möller HJ; Schläfke S; Dienel A; Kasper S
Int J Psychiatry Clin Pract; 2017 Sep; 21(3):177-180. PubMed ID: 28319423
[TBL] [Abstract][Full Text] [Related]
23. Characterization of anxiolytic and neuropharmacological activities of Silexan.
Kumar V
Wien Med Wochenschr; 2013 Feb; 163(3-4):89-94. PubMed ID: 23361848
[TBL] [Abstract][Full Text] [Related]
24. Effects of lavender on anxiety: A systematic review and meta-analysis.
Donelli D; Antonelli M; Bellinazzi C; Gensini GF; Firenzuoli F
Phytomedicine; 2019 Dec; 65():153099. PubMed ID: 31655395
[TBL] [Abstract][Full Text] [Related]
25. How Strong is the Evidence for the Anxiolytic Efficacy of Lavender?: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Kang HJ; Nam ES; Lee Y; Kim M
Asian Nurs Res (Korean Soc Nurs Sci); 2019 Dec; 13(5):295-305. PubMed ID: 31743795
[TBL] [Abstract][Full Text] [Related]
26. Lavender Oil Preparation (Silexan) for Treating Anxiety: An Updated Meta-Analysis.
Generoso MB; Soares A; Taiar IT; Cordeiro Q; Shiozawa P
J Clin Psychopharmacol; 2017 Feb; 37(1):115-117. PubMed ID: 27861196
[No Abstract] [Full Text] [Related]
27. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
28. Silexan, an essential oil from flowers of Lavandula angustifolia, is not recognized as benzodiazepine-like in rats trained to discriminate a diazepam cue.
Silenieks LB; Koch E; Higgins GA
Phytomedicine; 2013 Jan; 20(2):172-7. PubMed ID: 23207249
[TBL] [Abstract][Full Text] [Related]
29. Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder.
Uehleke B; Schaper S; Dienel A; Schlaefke S; Stange R
Phytomedicine; 2012 Jun; 19(8-9):665-71. PubMed ID: 22475718
[TBL] [Abstract][Full Text] [Related]
30. Phytopharmaceutical treatment of anxiety, depression, and dementia in the elderly: evidence from randomized, controlled clinical trials.
Kasper S
Wien Med Wochenschr; 2015 Jun; 165(11-12):217-28. PubMed ID: 26092515
[TBL] [Abstract][Full Text] [Related]
31. Psychiatric manifestations of post-COVID-19 syndrome: the potential benefit of Silexan.
Kasper S; Eckert A; Möller HJ; Volz HP; Seifritz E
Int J Psychiatry Clin Pract; 2023 Sep; 27(3):285-291. PubMed ID: 37021969
[No Abstract] [Full Text] [Related]
32. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
[TBL] [Abstract][Full Text] [Related]
33. Drug cocktail interaction study on the effect of the orally administered lavender oil preparation silexan on cytochrome P450 enzymes in healthy volunteers.
Doroshyenko O; Rokitta D; Zadoyan G; Klement S; Schläfke S; Dienel A; Gramatté T; Lück H; Fuhr U
Drug Metab Dispos; 2013 May; 41(5):987-93. PubMed ID: 23401474
[TBL] [Abstract][Full Text] [Related]
34. Topical lavender oil for the treatment of recurrent aphthous ulceration.
Altaei DT
Am J Dent; 2012 Feb; 25(1):39-43. PubMed ID: 22558691
[TBL] [Abstract][Full Text] [Related]
35. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
Griebel G; Beeské S; Stahl SM
J Clin Psychiatry; 2012 Nov; 73(11):1403-11. PubMed ID: 23146246
[TBL] [Abstract][Full Text] [Related]
36. [Special lavender oil. New phytotherapy anxiolytic drug for sub-syndromal anxiety disorders].
MMW Fortschr Med; 2010 Mar; 152(9):86-7. PubMed ID: 20384107
[No Abstract] [Full Text] [Related]
37. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
38. The best route of administration of lavender for anxiety: a systematic review and network meta-analysis.
Sayed AM; Morsy S; Tawfik GM; Naveed S; Minh-Duc NT; Hieu TH; Ali ZA; Shinkar A; Doheim MF; Hashan MR; Huy NT
Gen Hosp Psychiatry; 2020; 64():33-40. PubMed ID: 32088511
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.
Herrera-Arellano A; Jiménez-Ferrer JE; Zamilpa A; García-Alonso G; Herrera-Alvarez S; Tortoriello J
Planta Med; 2012 Sep; 78(14):1529-35. PubMed ID: 22828921
[TBL] [Abstract][Full Text] [Related]
40. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
